# Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19

> **NCT04273646** · NA · UNKNOWN · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 48 (estimated)

## Conditions studied

- 2019 Novel Coronavirus Pneumonia
- COVID-19

## Interventions

- **BIOLOGICAL:** UC-MSCs
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04273646
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-20
- **Primary completion:** 2020-06-30
- **Final completion:** 2022-02-15
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2020-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04273646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04273646, "Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04273646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*